• Explore /
  • Poster
  • / A phase I/II trial of pazopanib alternating with bevacizumab in treatment-naïve metastatic clear cell renal cell carcinoma (CCRCC) patients: Phase I results.

A phase I/II trial of pazopanib alternating with bevacizumab in treatment-naïve metastatic clear cell renal cell carcinoma (CCRCC) patients: Phase I results.

Abstract Poster

Authors

Saby George

Saby George

Roswell Park Comprehensive Cancer Center, Buffalo, NY

Saby George , Laurie Herbst , Marcus Sikorski , Ann Marie Diraddo , Gissou Azabdaftari , Charles Roche , Eric Kauffman , Qiang Li , Thomas Schwaab , Ellis Glenn Levine , Roberto Pili , Gurkamal S. Chatta , Leonard Joseph Appleman , Adrienne Groman , Rahul Atul Parikh , Alan Hutson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Clinical Trial Registration Number

NCT01684397

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 561)

DOI

10.1200/JCO.2019.37.7_suppl.561

Abstract #

561

Poster Bd #

D22

Abstract Disclosures

Similar Posters

First Author: Rohan Garje

First Author: David I. Quinn

First Author: Martin Henner Voss

First Author: Fabio Augusto Barros Schutz